Siponimod slowed disability progression in secondary progressive multiple sclerosis
Venetoclax still under review in Europe.
US researchers develop bio-degradable battery powered by melanin.
EC wants pharma to make clinical trial results more patient-friendly.
Snapshot of clinical trial application processes in the region.
A round-up of this week’s top digital healthcare news. Marco Ricci reports.